{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:17:26Z","timestamp":1770884246611,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00210-025-04610-0","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T07:55:32Z","timestamp":1758182132000},"page":"2903-2913","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["An analysis of the association between atypical antipsychotic drugs and glaucoma risk: a disproportionality assessment based on the FAERS database"],"prefix":"10.1007","volume":"399","author":[{"given":"Weiwen","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongdong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junyi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liuyin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"key":"4610_CR1","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/gps.4327","volume":"30","author":"A Achiron","year":"2015","unstructured":"Achiron A, Aviv U, Mendel L, Burgansky-Eliash Z (2015) Acute angle closure glaucoma precipitated by olanzapine. Int J Geriatr Psychiatry 30:1101\u20131102","journal-title":"Int J Geriatr Psychiatry"},{"key":"4610_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ogla.2024.04.006","volume":"7","author":"OM Aftab","year":"2024","unstructured":"Aftab OM, Khan H, Khouri AS (2024) Blind spots in therapy: unveiling drug-induced angle-closure glaucoma through a national analysis. Ophthalmol Glaucoma 7:485\u2013490","journal-title":"Ophthalmol Glaucoma"},{"key":"4610_CR3","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.934432","volume":"22","author":"MA Alarfaj","year":"2021","unstructured":"Alarfaj MA, Almater AI (2021) Olanzapine-induced acute angle closure. Am J Case Rep 22:e934432","journal-title":"Am J Case Rep"},{"key":"4610_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.pharmthera.2018.06.012","volume":"192","author":"S Aringhieri","year":"2018","unstructured":"Aringhieri S, Carli M, Kolachalam S, Verdesca V, Cini E, Rossi M, McCormick PJ, Corsini GU, Maggio R, Scarselli M (2018) Molecular targets of atypical antipsychotics: from mechanism of action to clinical differences. Pharmacol Ther 192:20\u201341","journal-title":"Pharmacol Ther"},{"key":"4610_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s002280050466","volume":"54","author":"A Bate","year":"1998","unstructured":"Bate A, Lindquist M, Edwards IR, Olsson S, Orre R, Lansner A, De Freitas RM (1998) A bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol 54:315\u2013321","journal-title":"Eur J Clin Pharmacol"},{"key":"4610_CR6","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.2174\/1570159X18666200818194948","volume":"19","author":"M Carli","year":"2021","unstructured":"Carli M, Aringhieri S, Kolachalam S, Longoni B, Grenno G, Rossi M, Gemignani A, Fornai F, Maggio R, Scarselli M (2021) Is adult hippocampal neurogenesis really relevant for the treatment of psychiatric disorders? Curr Neuropharmacol 19:1640\u20131660","journal-title":"Curr Neuropharmacol"},{"key":"4610_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.schres.2006.07.011","volume":"88","author":"ML Chew","year":"2006","unstructured":"Chew ML, Mulsant BH, Pollock BG, Lehman ME, Greenspan A, Kirshner MA, Bies RR, Kapur S, Gharabawi G (2006) A model of anticholinergic activity of atypical antipsychotic medications. Schizophr Res 88:63\u201372","journal-title":"Schizophr Res"},{"issue":"227\u2013232","key":"4610_CR8","first-page":"e221","volume":"115","author":"V Chopra","year":"2008","unstructured":"Chopra V, Varma R, Francis BA, Wu J, Torres M, Azen SP (2008) Los Angeles latino eye study G: Type 2 diabetes mellitus and the risk of open-angle glaucoma the Los Angeles latino eye study. Ophthalmology 115(227\u2013232):e221","journal-title":"Ophthalmology"},{"key":"4610_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10132947","author":"AM Ciobanu","year":"2021","unstructured":"Ciobanu AM, Dionisie V, Neagu C, Bolog OM, Riga S, Popa-Velea O (2021) Psychopharmacological treatment, intraocular pressure and the risk of glaucoma: a review of literature. J Clin Med. https:\/\/doi.org\/10.3390\/jcm10132947","journal-title":"J Clin Med"},{"issue":"3","key":"4610_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/00031305.1999.10474456","volume":"53","author":"W DuMouchel","year":"1999","unstructured":"DuMouchel W (1999) Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. Am Stat 53(3):177\u2013190","journal-title":"Am Stat"},{"key":"4610_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pds.677","volume":"10","author":"SJ Evans","year":"2001","unstructured":"Evans SJ, Waller PC, Davis S (2001) Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 10:483\u2013486","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"4610_CR12","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.ophtha.2003.12.052","volume":"111","author":"FW Fraunfelder","year":"2004","unstructured":"Fraunfelder FW, Fraunfelder FT (2004) Adverse ocular drug reactions recently identified by the National Registry of Drug-Induced Ocular Side Effects. Ophthalmology 111:1275\u20131279","journal-title":"Ophthalmology"},{"key":"4610_CR13","doi-asserted-by":"publisher","first-page":"306","DOI":"10.24869\/psyd.2022.306","volume":"34","author":"G Gokgoz Ozisik","year":"2022","unstructured":"Gokgoz Ozisik G, Caglar C (2022) Acute angle closure in a patient using olanzapine. Psychiatr Danub 34:306\u2013307","journal-title":"Psychiatr Danub"},{"key":"4610_CR14","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1016\/j.ophtha.2009.06.042","volume":"116","author":"A Heijl","year":"2009","unstructured":"Heijl A, Bengtsson B, Hyman L, Leske MC, Early Manifest Glaucoma Trial G (2009) Natural history of open-angle glaucoma. Ophthalmology 116:2271\u20132276","journal-title":"Ophthalmology"},{"key":"4610_CR15","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/S0140-6736(23)01289-8","volume":"402","author":"H Jayaram","year":"2023","unstructured":"Jayaram H, Kolko M, Friedman DS, Gazzard G (2023) Glaucoma: now and beyond. Lancet 402:1788\u20131801","journal-title":"Lancet"},{"key":"4610_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jad.2023.11.025","volume":"346","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Zhou L, Shen Y, Zhou Q, Ji Y, Zhu H (2024) Safety assessment of Brexpiprazole: real-world adverse event analysis from the FAERS database. J Affect Disord 346:223\u2013229","journal-title":"J Affect Disord"},{"key":"4610_CR17","doi-asserted-by":"crossref","unstructured":"Peuskens Marc De Hert Michael Jones J (2001) The clinical value of risperidone and olanzapine: A meta-analysis of efficacy and safety. Int J Psychiatry Clin Pract 5:179\u2013187","DOI":"10.1080\/136515001317021644"},{"key":"4610_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2019.105173","volume":"143","author":"SV Joshi","year":"2020","unstructured":"Joshi SV, Patel EP, Vyas BA, Lodha SR, Kalyankar GG (2020) Repurposing of iloperidone: Antihypertensive and ocular hypotensive activity in animals. Eur J Pharm Sci 143:105173","journal-title":"Eur J Pharm Sci"},{"key":"4610_CR19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev.med.52.1.503","volume":"52","author":"S Kapur","year":"2001","unstructured":"Kapur S, Remington G (2001) Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia. Annu Rev Med 52:503\u2013517","journal-title":"Annu Rev Med"},{"issue":"7","key":"4610_CR20","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0161-6420(94)31191-2","volume":"101","author":"BE Klein","year":"1994","unstructured":"Klein BE, Klein R, Jensen SC (1994) Open-angle glaucoma and older-onset diabetes. The Beaver Dam Eye Study. Ophthalmology 101(7):1173\u20131177","journal-title":"Ophthalmology"},{"key":"4610_CR21","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.exer.2011.08.007","volume":"93","author":"Y Liu","year":"2011","unstructured":"Liu Y, Allingham RR (2011) Molecular genetics in glaucoma. Exp Eye Res 93:331\u2013339","journal-title":"Exp Eye Res"},{"key":"4610_CR22","doi-asserted-by":"publisher","first-page":"106S","DOI":"10.1038\/sj.npp.1395370","volume":"21","author":"HY Meltzer","year":"1999","unstructured":"Meltzer HY (1999) The role of serotonin in antipsychotic drug action. Neuropsychopharmacology 21:106S-115S","journal-title":"Neuropsychopharmacology"},{"key":"4610_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/sj.mp.4002066","volume":"13","author":"HA Nasrallah","year":"2008","unstructured":"Nasrallah HA (2008) Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry 13:27\u201335","journal-title":"Mol Psychiatry"},{"issue":"Pt 3B","key":"4610_CR24","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/eye.2000.131","volume":"14","author":"NN Osborne","year":"2000","unstructured":"Osborne NN, Wood JP, Melena J, Chao HM, Nash MS, Bron AJ, Chidlow G (2000) 5-hydroxytryptamine1a agonists: potential use in glaucoma. Evidence from animal studies. Eye (Lond) 14(Pt 3B):454\u2013463","journal-title":"Eye (Lond)"},{"key":"4610_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.17116\/oftalma2020136021107","volume":"136","author":"OD Ostroumova","year":"2020","unstructured":"Ostroumova OD, Shikh EV, Rebrova EV, Ryazanova AY, Moshetova LK (2020) Drug-induced glaucoma. Vestn Oftalmol 136:107\u2013116","journal-title":"Vestn Oftalmol"},{"key":"4610_CR26","first-page":"3460","volume":"41","author":"HA Quigley","year":"2000","unstructured":"Quigley HA, McKinnon SJ, Zack DJ, Pease ME, Kerrigan-Baumrind LA, Kerrigan DF, Mitchell RS (2000) Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats. Invest Ophthalmol vis Sci 41:3460\u20133466","journal-title":"Invest Ophthalmol vis Sci"},{"key":"4610_CR27","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2165\/11533180-000000000-00000","volume":"24","author":"S Richa","year":"2010","unstructured":"Richa S, Yazbek JC (2010) Ocular adverse effects of common psychotropic agents: a review. CNS Drugs 24:501\u2013526","journal-title":"CNS Drugs"},{"key":"4610_CR28","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/pds.1001","volume":"13","author":"KJ Rothman","year":"2004","unstructured":"Rothman KJ, Lanes S, Sacks ST (2004) The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiol Drug Saf 13:519\u2013523","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"4610_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2165\/00003495-200767010-00006","volume":"67","author":"RM Santaella","year":"2007","unstructured":"Santaella RM, Fraunfelder FW (2007) Ocular adverse effects associated with systemic medications\u202f: recognition and management. Drugs 67:75\u201393","journal-title":"Drugs"},{"key":"4610_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/070674370204700106","volume":"47","author":"P Seeman","year":"2002","unstructured":"Seeman P (2002) Atypical antipsychotics: mechanism of action. Can J Psychiatry 47:27\u201338","journal-title":"Can J Psychiatry"},{"key":"4610_CR31","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1590\/S0004-27492008000500009","volume":"71","author":"VB Souza","year":"2008","unstructured":"Souza VB, Moura Filho FJ, Souza FG, Pereira Filho SA, Coelho SS, Furtado FA, Goncalves TB, Vasconcelos KF (2008) Intraocular pressure in schizophrenic patients treated with psychiatric medications. Arq Bras Oftalmol 71:660\u2013664","journal-title":"Arq Bras Oftalmol"},{"key":"4610_CR32","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY (2014) Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 121:2081\u20132090","journal-title":"Ophthalmology"},{"key":"4610_CR33","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/0735-6757(94)90248-8","volume":"12","author":"MJ Tueth","year":"1994","unstructured":"Tueth MJ (1994) Emergencies caused by side effects of psychiatric medications. Am J Emerg Med 12:212\u2013216","journal-title":"Am J Emerg Med"},{"key":"4610_CR34","doi-asserted-by":"crossref","unstructured":"Vallee A, Vallee JN, Lecarpentier Y (2021) Lithium and atypical antipsychotics: the possible WNT\/\u03b2-catenin pathway target in glaucoma. Biomedicines 9:653","DOI":"10.3390\/biomedicines9050473"},{"key":"4610_CR35","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","volume":"311","author":"RN Weinreb","year":"2014","unstructured":"Weinreb RN, Aung T, Medeiros FA (2014) The pathophysiology and treatment of glaucoma: a review. JAMA 311:1901\u20131911","journal-title":"JAMA"},{"key":"4610_CR36","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1177\/104012371102300208","volume":"23","author":"ML Zupancic","year":"2011","unstructured":"Zupancic ML (2011) Role of atypical antipsychotics in rapid cycling bipolar disorder: a review of the literature. Ann Clin Psychiatry 23:141\u2013149","journal-title":"Ann Clin Psychiatry"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04610-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04610-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04610-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:53:33Z","timestamp":1770882813000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04610-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4610"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04610-0","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,18]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study was deemed non-human subject related research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}